4//SEC Filing
Chard Daniel R 4
Accession 0001628280-23-014348
CIK 0000910329other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 8:42 AM ET
Size
12.0 KB
Accession
0001628280-23-014348
Insider Transaction Report
Form 4
MEDIFAST INCMED
Chard Daniel R
DirectorChairman & CEO
Transactions
- Tax Payment
Common Stock
2023-03-17$102.75/sh−872$89,598→ 30,321 total - Award
Common Stock
2023-03-17+16,807→ 47,128 total - Award
Common Stock
2023-02-24+34,076→ 48,194 total - Tax Payment
Common Stock
2023-03-16$104.46/sh−1,358$141,857→ 31,193 total - Tax Payment
Common Stock
2023-02-24$109.99/sh−15,643$1,720,574→ 32,551 total
Holdings
- 108,598.352(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]17,038 Performance Stock Units were granted on February 19, 2020, and vested on December 31, 2022 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 24, 2023 and the shares were released on March 7, 2023.
- [F2]Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.
Documents
Issuer
MEDIFAST INC
CIK 0000910329
Entity typeother
Related Parties
1- filerCIK 0001289557
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 8:42 AM ET
- Size
- 12.0 KB